A National Study of HPV Vaccination of Adolescent Girls: Rates, Predictors, and Reasons for Non-Vaccination
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Despite recommendations in the U.S. for routine HPV vaccination of adolescent girls since 2006, rates of vaccination continue to be low. This study reports vaccination uptake, factors associated with vaccine uptake and reasons for non-vaccination within a national sample of adolescent females during 2010. Using a computer administered survey of a national sample of 501 mothers of daughters 14–17 years old we assessed maternal reports of HPV vaccination as well as socio-demographical factors, maternal HPV exposures and reasons chosen for non-vaccination. Reported HPV vaccination rates were slightly over 50 % (51.1 %), with 38.3 % reporting completion of all 3 doses. Socioeconomic and demographic factors were not associated with vaccination initiation; however, Blacks and Hispanics were less likely to complete vaccination. The most common reasons for non-vaccination were concerns about vaccine safety, danger to daughter, and provider non-recommendation. Relatively poor HPV vaccine initiation and only modest 3-dose completion continues to be a major public health concern that requires continued efforts to address identified predictors and reasons for non-vaccination.
- Morbidity and Mortality Weekly Report (MMWR). (2007). Quadrivalent human papillomavirus vaccine. CDC, 56(RR02), 1–24. www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm.
- Morbidity and Mortality Weekly Report (MMWR). (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). CDC, 59(20), 626–629. www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm.
- Morbidity and Mortality Weekly Report (MMWR). (2007). QuickStats: Prevalence of HPV infection among sexually active females aged 14–59 years by age group. National Health and Nutrition Examination Survey, United States 2003–2004. CDC. www.cdc.gov/mmwr/preview/mmwrhtml/mm5633a5.htm.
- Weaver, B., Shew, M., Qadadri, B., et al. (2011). Natural history of multiple human papillomavirus infections in female adolescents with prolonged follow-up. Journal of Adolescent Health, 48(5), 473–480. CrossRef
- Morbidity and Mortality Weekly Report (MMWR). (2010). National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009. CDC, 59(32):1018–1023. www.cdc.gov/mmwr/preview/mmwrhtml/mm5932a3.htm?s_cid=mm5932a3_e%0d%0a.
- Morbidity and Mortality Weekly Report (MMWR). (2011). National and state vaccination coverage among adolescents aged 13 through 17 years—United States, 2010. CDC, 60(33). http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6033a1.htm.
- Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45(2–3), 107–114. CrossRef
- Guerry, S. L., De Rosa, C. J., Markowitz, L. E., et al. (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine, 29(12), 2235–2241. CrossRef
- Smith, L., Brassard, P., Kwong, J., Deeks, S., Ellis, A., & Levesque, L. (2011). Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls. BMC Public Health, 11(1), 645. CrossRef
- Fernández, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010). Integrating clinical, community, and policy perspectives on HPV vaccination. Annual Review of Public Health, 31, 235–252. CrossRef
- Dorell, C. G., Yankey, D., Santibanez, T. A., & Markowitz, L. E. (2011). Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics, 128(5), 830–839. CrossRef
- Barnack, J. L., Reddy, D. M., & Swain, C. (2010). Predictors of parents’ willingness to vaccinate for human papillomavirus and physicians’ intentions to recommend the vaccine. Women’s Health Issues, 20(1), 28–34. CrossRef
- Allen, J. D., Othus, M. K. D., Shelton, R. C., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187–2198. CrossRef
- Brewer, N. T., Gottlieb, S. L., Reiter, P. L., et al. (2011). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases, 38(3), 197–204. CrossRef
- Pruitt, S. L., & Schootman, M. (2010). Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine, 38(5), 525–533. CrossRef
- Widdice, L. E., Bernstein, D. I., Leonard, A. C., Marsolo, K. A., & Kahn, J. A. (2011). Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics, 127(1), 77–84. CrossRef
- Schluterman, N., Terplan, M. S., Lydecker, A. D., & Tracy, J. K. (2011). Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine, 29(21), 3767–3772. CrossRef
- Gold, R., Naleway, A. L., Jenkins, L. L., et al. (2011). Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in oregon. Preventive Medicine, 52(6), 456–458. CrossRef
- Chou, B., Krill, L. S., Horton, B. B., Barat, C. E., & Trimble, C. L. (2011). Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstetrics & Gynecology, 118(1), 14–20. CrossRef
- Niccolai, L. M., Mehta, N. R., & Hadler, J. L. (2011). Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. American Journal of Preventive Medicine, 41(4), 428–433. CrossRef
- Society, A. C. (2010). Cancer facts and figures 2010. Alanta: American Cancer Society.
- Bingham, A., Drake, J. K., & LaMontagne, D. S. (2009). Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Archives of Pediatrics & Adolescent Medicine, 163(5), 455–461.
- Kahn, J. A., Lan, D., & Kahn, R. S. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics & Gynecology, 110(1), 87–95. CrossRef
- Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45(5), 453–462. CrossRef
- Chao, C., Slezak, J. M., Coleman, K. J., & Jacobsen, S. J. (2009). Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. American Journal of Public Health, 99(6), 1137–1142. CrossRef
- Gerend, M. A., Weibley, E., & Bland, H. (2009). Parental response to human papillomavirus vaccine availability: Uptake and intentions. Journal of Adolescent Health, 45(5), 528–531. CrossRef
- Dorell, C., Yankey, D., & Strasser, S. (2011). Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey—Teen, 2009. Clinical Pediatrics, 50(12), 1116–1124. CrossRef
- Daley, M. F., Crane, L. A., Markowitz, L. E., et al. (2010). Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure. Pediatrics, 126(3), 425–433. CrossRef
- A National Study of HPV Vaccination of Adolescent Girls: Rates, Predictors, and Reasons for Non-Vaccination
Maternal and Child Health Journal
Volume 17, Issue 5 , pp 879-885
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Vaccination rates
- Adolescent health behaviors
- Sexually transmitted infections
- Industry Sectors
- Author Affiliations
- 1. Department of Pediatrics, Indiana University, 410 W. 10th Street, Suite 1001, Indianapolis, IN, 46202, USA
- 2. Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA